The prevalent cases of Alzheimer's disease (AD) in the eight major markets globally are set to register an annual growth rate (AGR) of 4.08 per cent from 15.99 million in 2023 to 22.51 million in 2033 ...
Current diagnostic criteria from DSM-IV are listed in Table I. [6] In contrast to DSM-III-R, DSM-IV eliminated from the criteria the autonomic symptoms of anxiety: Although these symptoms are ...
Methods: Multicentre, randomised, double-blind, parallel-group clinical trial in 64 outpatients with GAD (DSM-IV criteria). Patients were assigned to mexazolam 1mg three times daily (n = 32 ...